Nausea and Vomiting Remain a Significant Clinical Problem

Slides:



Advertisements
Similar presentations
A one-year audit of topics and domains in the Journal of the American Medical Association and the New England Journal of Medicine1  Steven H Woolf, MD,
Advertisements

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
Factors to Inform Clinicians About the End of Life in Severe Chronic Obstructive Pulmonary Disease  Roberto Benzo, MD, MS, Wendy Siemion, MD, Paul Novotny,
Carmelita P. Escalante, MD, Michael A. Kallen, PhD, MPH, Rosalie U
An Exploratory Study on the Effects of an Expectancy Manipulation on Chemotherapy- Related Nausea  Joseph A. Roscoe, PhD, Michael O'Neill, MD, Pascal Jean-Pierre,
Wen Jing Chung, MD, MS, Gregory H. Pharo, DO 
The Concept of Quality of Life of Dying Persons in the Context of Health Care  Anita L Stewart, PhD, Joan Teno, MD, MS, Donald L Patrick, PhD, MSPH, Joanne.
To Drain or Not to Drain: An Evidence-Based Approach to Palliative Procedures for the Management of Malignant Pleural Effusions  Annette Beyea, DO, Gary.
Why Now? Timing and Circumstances of Hastened Deaths
The Impact of Chronic Pain on Life in the Household
Comparison of Tropisetron and Chlorpromazine Combinations in the Control of Nausea and Vomiting in Patients with Advanced Cancer  Kyriaki Mystakidou,
Anita L Comley, PhD, RN, AOCN, Elaine DeMeyer, RN, MSN, AOCN 
Advance Care Planning Does Not Adversely Affect Hope or Anxiety Among Patients With Advanced Cancer  Michael J. Green, MD, MS, FACP, Jane R. Schubart,
Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment  Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,
Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 
NMDA-Receptor Antagonists in Neuropathic Pain
Acupressure Bands Are Effective in Reducing Radiation Therapy-Related Nausea  Joseph A. Roscoe, PhD, Peter Bushunow, MD, Pascal Jean-Pierre, PhD, Charles.
The Efficacy of Acupressure and Acustimulation Wrist Bands for the Relief of Chemotherapy-Induced Nausea and Vomiting  Joseph A Roscoe, PhD, Gary R Morrow,
Exploring the Meaning of Chronic Rejection After Lung Transplantation and Its Impact on Clinical Management and Caregiving  Mi-Kyung Song, PhD, RN, Annette.
Complementary and Alternative Medicine in the Management of Pain, Dyspnea, and Nausea and Vomiting Near the End of Life  Cynthia X. Pan, MD, R.Sean Morrison,
Qiuling Shi, MD, PhD, MSc, Peter C
African American Bereaved Family Members' Perceptions of the Quality of Hospice Care: Lessened Disparities, But Opportunities to Improve Remain  Ramona.
Factors to Inform Clinicians About the End of Life in Severe Chronic Obstructive Pulmonary Disease  Roberto Benzo, MD, MS, Wendy Siemion, MD, Paul Novotny,
Samuel J Hassenbusch, MD, PhD, Russell K Portenoy, MD 
Transdermal Fentanyl for Chronic Pain in AIDS
Temporary Sympathectomy in the Treatment of Chronic Refractory Angina
Life-Sustaining Treatment Preferences: Matches and Mismatches Between Patients' Preferences and Clinicians' Perceptions  Lois Downey, MA, David H. Au,
Redefining Appropriate Treatment Expectations
Development of a symptom assessment instrument for chronic hemodialysis patients: the dialysis symptom index  Steven D Weisbord, MD, Linda F Fried, MD,
Treatment of chronic autoimmune urticaria with omalizumab
Long-Term Safety and Efficacy of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules, a Novel Formulation Containing Morphine and.
The Effects of Family Support, Anxiety, and Post-Treatment Nausea on the Development of Anticipatory Nausea: A Latent Growth Model  Youngmee Kim, PhD,
Jodi L. Hannan, MD, Steven M. Radwany, MD, Terry Albanese, PhD 
Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD 
Cancer patients' share in a population's Use of opioids
The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer  Jane T. Hickok, MD, MPH, Joseph A. Roscoe,
Palliative Care Needs and Symptom Patterns of Hospitalized Elders Referred for Consultation  Aaron M. Olden, MD, MS-CLI, Robert Holloway, MD, MPH, Susan.
Robert L. Jayes, MD, Robert M. Arnold, MD, Erik K. Fromme, MD 
Acustimulation Wrist Bands Are Not Effective for the Control of Chemotherapy-Induced Nausea in Women with Breast Cancer  Joseph A. Roscoe, PhD, Sara E.
Susan C. Miller, PhD, Dan K. Kiely, MPH, MA, Joan M
Prevalence and Characteristics of Breakthrough Pain in Cancer Patients Admitted to a Hospice  Giovambattista Zeppetella, BSc (Hons), MRCGP, Catherine.
Antonio T. Fernando, MD, Nathan S. Consedine, PhD 
Improving Access to Opioid Analgesics for Palliative Care in India
Drug Infusors in Palliative Medicine
The Assessment of Cancer Pain in North India
Cancer Pain Education Journal of Pain and Symptom Management
U.S. Hospice Benefits Journal of Pain and Symptom Management
Alexander K. Smith, MD, MS, MPH, Christine S
Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD 
The impact of demographic and disease-specific variables on pain in cancer patients  Tone Rustøen, RN, PhD, Sophie D Fosså, MD, Dr Med Sci, Jon Skarstein,
Association Between Symptom Distress and Survival in Outpatients Seen in a Palliative Care Cancer Center  J. Lynn Palmer, PhD, Michael J. Fisch, MD, MPH 
Long-Term Safety of MorphiDex®
Evaluating the Quality of Dying and Death
A Scale for Measuring Patient Perceptions of the Quality of End-of-Life Care and Satisfaction with Treatment  Daniel P. Sulmasy, OFM, MD, PhD, Jessica.
Psychometric update of the Functional Interference Estimate: a brief measure of pain functional interference  Robert J. Ferguson, PhD, Janette Seville,
Risk for Incident Renal Dialysis in a Managed Care Population
Clinical and Economic Impact of Palliative Care Consultation
A Meta-Analysis of the Relationship Between Response Expectancies and Cancer Treatment-Related Side Effects  Stephanie J. Sohl, PhD, Julie B. Schnur,
Knowledge and Attitudes of Italian Medical Staff Towards the Approach and Treatment of Patients in Pain  Marco Visentin, MD, Leonardo Trentin, MD, Roberto.
A Preliminary Study of the Utility of the Brief Hospice Inventory
The Asia Pacific Hospice Palliative Care Network
A Titrated Morphine Analgesic Regimen Comparing Substance Users and Non-Users with AIDS-Related Pain  Ronald Kaplan, MD, Joseph Slywka, PhD, Susan Slagle,
Physical Function in Patients with Cancer
Treatment of Nausea and Emesis During Cancer Chemotherapy
Gerd Inger Ringdal, PhD, Marit S Jordhøy, MD, Stein Kaasa, PhD 
Multidimensional independent predictors of cancer-related fatigue
Helping Patients with Advanced Cancer Live with Concerns About Eating: A Challenge for Palliative Care Professionals  Jane Hopkinson, PhD, RGN, Jessica.
How Should End-of-Life Advance Care Planning Discussions Be Implemented According to Patients and Informal Carers? A Qualitative Review of Reviews  Alex.
Fatigue in Gynecological Cancer Patients During and After Anticancer Treatment  Gillian Prue, PhD, James Allen, PhD, Jacqueline Gracey, PhD, Jane Rankin,
Physical Activity Behaviors in Individuals with Multiple Sclerosis: Roles of Overall and Specific Symptoms, and Self-Efficacy  Erin M. Snook, MS, Robert.
Presentation transcript:

Nausea and Vomiting Remain a Significant Clinical Problem Joseph A Roscoe, PhD, Gary R Morrow, PhD, MS, Jane T Hickok, MD, MPH, Robert M Stern, PhD  Journal of Pain and Symptom Management  Volume 20, Issue 2, Pages 113-121 (August 2000) DOI: 10.1016/S0885-3924(00)00159-7

Fig. 1 Proportion of patients receiving 5-HT3 receptor antagonists Journal of Pain and Symptom Management 2000 20, 113-121DOI: (10.1016/S0885-3924(00)00159-7)

Fig. 2 Vomiting measured at four treatment cycles. Symbols represent proportion of patients reporting symptom Journal of Pain and Symptom Management 2000 20, 113-121DOI: (10.1016/S0885-3924(00)00159-7)

Fig. 3 Nausea measured at four treatment cycles. Symbols represent proportion of patients reporting symptom Journal of Pain and Symptom Management 2000 20, 113-121DOI: (10.1016/S0885-3924(00)00159-7)

Fig. 4 Average duration per incident Journal of Pain and Symptom Management 2000 20, 113-121DOI: (10.1016/S0885-3924(00)00159-7)